DNA-based nanonetworks have a wide range of promising use cases, especially in the field of medicine. With a large set of agents, a partially observable stochastic environment, and noisy observations, such nanoscale systems can be modelled as a decentralised, partially observable, Markov decision process (DecPOMDP). As the agent set is a dominating factor, this paper presents (i) lifted DecPOMDPs, partitioning the agent set into sets of indistinguishable agents, reducing the worst-case space required, and (ii) a nanoscale medical system as an application. Future work turns to solving and implementing lifted DecPOMDPs.
翻译:基于脱氧核糖核酸的纳米网络有多种有希望的使用案例,特别是在医学领域。随着大量的制剂、部分可观测的随机环境以及噪音观测,这类纳米规模系统可以仿照分散的、部分可观测的、Markov决策程序(DecPOMDP ) 。由于该制剂组是一个主导因素,本文件介绍了(一) 解除DecPOMDPs,将该制剂分成一系列无法区分的制剂,减少最坏情况所需的空间,以及(二) 纳米规模的医疗系统作为一种应用。未来的工作转向解决和实施已取消的DecPOMDPs。